OPTITHYDOSE
LIVE

Serial Number

79421670

Owner

Universität Basel

Attorney

Paul Cosmovici

Filing Date

Dec 16, 2024

Add to watchlist:

No watchlists yet
View on USPTO

OPTITHYDOSE Trademark

Serial Number: 79421670 • Registration: 8248553

OPTITHYDOSE is a trademark filed by Universität Basel on December 16, 2024. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Universität Basel (3 trademarks)

Vizerektorat Forschung / Unitectra
Basel 4003 , CH

Entity Type: 99

Trademark Details

Filing Date

December 16, 2024

Registration Date

May 12, 2026

Published for Opposition

March 24, 2026

Goods & Services

Downloadable software for predicting disease progression and determining an optimal drug dosing regimen; Recorded software for predicting disease progression and determining an optimal drug dosing regimen; downloadable Software as Medical Devices (SaMD) for predicting disease progression and determining an optimal drug dosing regimen; downloadable mobile applications for use with mobile devices for predicting disease progression and determining an optimal drug dosing regimen

Collection, systematization and input of information in databases, analysis and evaluation of data in a central file, namely, collection and compilation of information into computer databases in the fields of healthcare and medical science

Scientific and technological services, namely, research and design services in the field of disease progression and drug dosing; industrial analysis and research services, namely, scientific research and analysis in the field of disease progression and drug dosing; design and development of computers and software; development and testing of computing methods, algorithms and software, namely, design and development of new products for others in the field of computing and software; design and development of medical technology products for others; scientific research services in the field of disease progression and drug dosing for medical purposes; provision of medical and scientific research information in the field of pharmaceutical products and clinical trials

Health care services, medical services, provision of medical information; medical care and analysis services relating to patient treatment; performing disease diagnosis services

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 12, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
May 12, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 24, 2026 NPUB
PUBLISHED FOR OPPOSITION
Mar 24, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 18, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 2, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 26, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 26, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 26, 2026 TROA
REFUSAL PROCESSED BY IB
Aug 16, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 28, 2025 RFCS
REFUSAL PROCESSED BY MPU
Jul 28, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 6, 2025 RFCR
NON-FINAL ACTION WRITTEN
Jun 5, 2025 CNRT
ASSIGNED TO EXAMINER
Jun 3, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 25, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 25, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 17, 2025 REPR